Mesothelioma
212
38
54
79
Key Insights
Highlights
Success Rate
66% trial completion
Published Results
43 trials with published results (20%)
Research Maturity
79 completed trials (37% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
18.9%
40 terminated out of 212 trials
66.4%
-20.2% vs benchmark
5%
11 trials in Phase 3/4
54%
43 of 79 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 79 completed trials
Clinical Trials (212)
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
FAPI PET Imaging - An Exploratory Study
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A Study of SGN-MesoC2 in Advanced Solid Tumors
Prospective Data Collection Initiative on Thoracic Malignancies
Lead-212 PSV359 Therapy for Patients With Solid Tumors
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
Integrated Cancer Repository for Cancer Research
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma